According to the Drugs and Therapeutics Bulletin, Grazax - a new sublingual immunotherapy for grass allergies - is simply not cost effective. Research shows that the benefits to patients are quite modest, while the cost is quite high. Grazax is on the market England and costs £67.50 (about $100) for ...

Allergy shots for hayfever may become a thing of the past: a new treatment called Grazax might just win over those who hate needles. Grazax is a prescription medication that has already been approved in Europe. It's specifically targeted at hayfever and grass pollen allergies. Unlike traditional immunotherapy which requires a ...

If you thought that the only way to get allergy shots against grass allergens was in your arm, think again. Alk-Abello, a company out of Denmark, has developed a product called GRAZAX®. Grazax is a once daily allergy "vaccination" tablet: the principle is the same as other immunotherapy approaches, but there ...

Sublingual immunotherapy (SLIT) is used in Europe and other countries, but is still not being used in the US. The American College of Allergy, Asthma and Immunology says that there are still unanswered questions on the treatment's effectiveness, use, dosage and safety. Apparently, US research studies have not yet shown ...

MILWAUKEE – If you are interested in allergy shots but can’t stand a needle, there’s a new treatment option being used in Europe, Asia and Australia that could be coming in the next few years to the US. The major barrier at this point is an FDA-approved ...